Navigation Links
High-Dose Vitamin B Risky for Diabetics With Kidney Disease
Date:4/27/2010

Study ties therapy to deteriorating renal function

TUESDAY, April 27 (HealthDay News) -- High-dose vitamin B therapy is dangerous for diabetics with kidney disease, and patients on this regimen should stop immediately, says a new study.

When the researchers began the study, they believed it would show that high-dose vitamin B therapy (folic acid, vitamin B6 and vitamin B12) would improve patients' kidney function and reduce their risk of heart attack and stroke.

But it turned out that patients on high-dose vitamin B therapy had significant worsening of kidney function, and twice as many heart and stroke incidents as patients taking a placebo.

"Because B vitamins are water soluble, we suspect that while healthy people would excrete excess vitamins in urine, those with renal failure would not be able to do so, perhaps causing the adverse effects we have seen in this study," Dr. David Spence, of the University of Western Ontario in Canada, said in a university news release.

"Vitamin B therapy may still be beneficial in people with normal kidney function, but this is clear evidence that high doses of vitamin B should not be given to those with kidney problems," he added.

The study is published in the April 28 issue of the Journal of the American Medical Association.

More than 40 percent of people with diabetes develop kidney disease.

More information

The National Kidney Foundation has more about diabetes and kidney disease.



-- Robert Preidt



SOURCE: University of Western Ontario, news release, April 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Instaflex Announces Partnership with GNC, the Nation's Leading Vitamin and Supplement Retailer
2. Better vitamin D status could mean better quality of life for seniors
3. Vitamin K may protect against developing non-Hodgkins lymphoma, say Mayo Clinic researchers
4. B-vitamins Help Protect Against Stroke, Heart Disease
5. Low vitamin D levels associated with more asthma symptoms and medication use
6. Vitamins C, E Wont Cut Risk of Pregnancy-Linked Hypertension
7. Minority Kids Lack Enough Vitamin D
8. SumNuts Vitamin Nuts Launched, Enhanced with Vitamin D3 and Calcium
9. Too Many Infants Short on Vitamin D
10. Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids
11. Boosting Vitamin D Can Do a Heart Good
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... completed Course II of the HP3 (High-Performance Periodontal Practice) continuing education (CE) series. ... the latest advancements in his field by attending numerous CE courses each year. ...
(Date:5/24/2017)... ... , ... If you are thinking of a visit to San Francisco , fall is ... perfect time to visit. , Business Architecture Associates is pleased to offer 5 days of ... a 4-½ day package for individuals, and as 4-½ day corporate package for up to ...
(Date:5/24/2017)... ... May 24, 2017 , ... Fiberstar, Inc., http://www.FiberstarIngredients.com ... food and beverage industry offers Citri-Fi®, a natural citrus fiber, to improve beverage ... process. As a result, labels need to deliver simple, transparent and clear messaging. ...
(Date:5/23/2017)... SANTA CLARA, CA (PRWEB) , ... May 23, 2017 , ... ... government and financial organizations, today announced CIO Applications magazine has named the company a ... of its innovative use of the Cloud to help organizations simply and proactively address ...
(Date:5/23/2017)... N.Y. (PRWEB) , ... May 23, 2017 , ... New ... Public Health Crisis Worthy of a Policy Response”, -The Rory Staunton Foundation Calls on ... Staunton Foundation for the Prevention of Sepsis ( http://www.rorystauntonfoundation.org ) today reported on a ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... , May 22, 2017  As the ... a whole continue to make the revolutionary shift ... increasingly important for ensuring positive patient outcomes and ... stakeholders are shifting focus away from clinical trials ... effects of long-term specialty drug therapy utilization in ...
(Date:5/15/2017)... -- Enterin Inc., a privately-held CNS pharmaceutical company based in ... treat Parkinson,s disease (PD), has enrolled the first patient in ... controlled, multicenter study involving patients with PD and taking place ... a 9-to-12-month period. The first stage is open label and ... sites include Denver , Boca ...
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading ... , published its 2017 ranking of the Best-Equipped Hospitals ... data analysis from GHI,s hospitals database for Latin America ... region. The GHI database covers 86% of the hospitals in ... data points for each institution in key areas such as ...
Breaking Medicine Technology: